Jacobs Levy Equity Management, Inc Dynavax Technologies Corp Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 116,874 shares of DVAX stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116,874
Previous 191,005
38.81%
Holding current value
$1.17 Million
Previous $2.48 Million
53.21%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding DVAX
# of Institutions
294Shares Held
121MCall Options Held
294KPut Options Held
77.6K-
Black Rock Inc. New York, NY21.9MShares$219 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$178 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$84.4 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$64 Million0.0% of portfolio
-
Chicago Capital, LLC5.23MShares$52.3 Million1.29% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.27B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...